BusinessTempus Announces New Initiative to Support Physicians Efforts to Deliver Personalized MedicineBy Nasdaq OMXMay 8, 2018, 5:27 PM UTC
BusinessARCA biopharma and Medtronic Extend Gencaro Clinical Trial Collaboration AgreementBy Nasdaq OMXApr 23, 2018, 12:31 PM UTC
BusinessVineti Completes $33.5 Million in Series B Financing to Accelerate Patient Access to Cell and Gene TherapiesBy Nasdaq OMXApr 16, 2018, 11:30 AM UTC
BusinessTreos Bio Announces Activation of U.S. Clinical Trial Site for Phase 1 Study of PolyPEPI™ Precision Cancer Vaccine for Patients with Metastatic Colorectal CancerBy Nasdaq OMXApr 11, 2018, 12:15 PM UTC
BusinessTodos Medical reports on results of clinical trials for its blood test for breast cancer screening (TM - B1) conducted at Kaplan Hospital in Rehovot, IsraelBy Nasdaq OMXMar 22, 2018, 12:00 PM UTC
BusinessTodos Medical initiates clinical trial of its blood test for breast cancer in Kaplan Hospital, Rehovot, Israel for subjects undergoing breast cancer screeningBy Nasdaq OMXMar 5, 2018, 1:02 PM UTC
BusinessTempus Launches Tempus xE, Whole Exome Sequencing to Empower Data-Driven Cancer Care and ResearchBy Nasdaq OMXFeb 22, 2018, 3:30 PM UTC
BusinessMr. David Ben Naim, CPA, MBA Joins Todos Medical as Chief Financial OfficerBy Nasdaq OMXFeb 6, 2018, 1:00 PM UTC
